pri-724

Small moleculeexperimental

Clinical trial activity

6 trials · 10 clinical orgs · 0 marketing orgs

Phase 1
5
Phase 2
3
Phase 3
0
Phase 4
0

Earliest trial started Feb 1, 2011 (NCT01302405)

Timeline

2010s

  1. Jan 1, 2011

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2015

    Earliest Phase 2 Sponsor(trial)

Indications

Mechanism of action

Chemistry & pharmacology

Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • pri-724
  • pri-724

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT03620474Phase 1/Phase 2 (Phase 2)Jul 24, 2018Japan Agency for Medical Research and Development, Kyushu University, National Center for Global Health and Medicine, Prism Research, Tokyo Metropolitan Komagome Hospital
NCT02413853Phase 2Nov 1, 2015National Cancer Institute (NCI), Prism Research, University of Southern California
NCT02195440Phase 1Aug 1, 2014Prism Research, Tokyo Metropolitan Komagome Hospital
NCT01764477Phase 1Apr 1, 2013inVentiv, Mayo Clinic, Prism Research
NCT01606579Phase 1/Phase 2 (Phase 2)Jul 1, 2012inVentiv, Prism Research, University of Texas at Houston
NCT01302405Phase 1Feb 1, 2011inVentiv, Prism Research, University of Southern California
Showing 6 of 6 trials
Page 1 / 1

Organizations

Research & Development (10)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Prism ResearchFor profit6322011
inVentivFor profit3022011
Tokyo Metropolitan Komagome HospitalAcademic/Hospital2222014
University of Southern CaliforniaAcademic/Hospital2122011
Japan Agency for Medical Research and DevelopmentGovernment1012018
Kyushu UniversityAcademic/Hospital1012018
Mayo ClinicAcademic/Hospital1012013
National Cancer Institute (NCI)Government1012015
National Center for Global Health and MedicineGovernment1012018
University of Texas at HoustonAcademic/Hospital1012012
10 organizations
Page 1 / 1